The Management Board of Mycodern S.A. with its seat in Gdansk, Poland, “the Company”, informs that today it has entered into an agreement with an entity with its seat in Poland, “the Partner”, on the basis of which it will produce sugar-free vegan jelly beans for the Partner. The Company will produce and deliver jellybeans …
22-01-2024 23:29:56 | Current | ESPI | 1/2024 The Management Board of Mycodern S.A., headquartered in Gdańsk _”the Company”_, in reference to ESPI Report No. 19/2023 dated 23/10/2023, informing of the publication of the announcement of the offer to subscribe for series E shares by shareholders with subscription rights, as well as ESPI Report No. …
08-01-2024 13:04:11 | Current | EBI | 1/2024 The Management Board of Mycodern SA, with its seat in Gdańsk, Poland (the “Company”) announces that today it has learned that the other party has signed, and thus entered into, an agreement with GLC AUDIT sp. z o.o., with its seat in Katowice, Poland (an entity registered …
30-12-2023 20:02:57 | Current | ESPI | 22/2023 The Management Board of Mycodern S.A. with its seat in Gdańsk _”the Company”_ informs that the Company has received notifications from shareholders, prepared in accordance with Article 69 of the Public Offering Act, regarding changes in voting shares, i.e: – from Mr. Michał Przyłęcki, on lowering the …
28-12-2023 22:28:09 | Current | ESPI | 21/2023 The Board of Directors of Mycodern S.A. with its registered seat in Gdansk __quot;Issuer_quot; or _quot;Company_quot;_, with reference to ESPI Report No. 19/2023 dated 23.10.2023, informing about the publication of the announcement of the offer to subscribe for series E shares by shareholders with subscription rights, as …
29-11-2023 14:02:54 | Current | ESPI | 20/2023 The Management Board of Mycodern S.A. with its registered seat in Gdańsk _ the “Issuer” or the “Company”_, in reference to the ESPI current report No. 19/2023 dated 23/10/2023, informing about the publication of an announcement on the offer to take up series E shares by shareholders …
14-11-2023 20:26:25 | Quarterly | EBI | 25/2023 The Management Board of Mycodern S.A. with its seat in Gdańsk (hereinafter: the Company) hereby publishes the consolidated interim report for Q3 2023. At the same time, the Management Board indicates that the Company does not separately publish the standalone report for the third quarter of 2023, …
23-10-2023 14:09:41 | Current | EBI | 24/2023 The Management Board of Mycodern S.A., with its registered office in Gdańsk (the “Company”), informs that today the Supervisory Board of the Company has appointed Ms. Wiktoria Groth, by way of co-optation, upon the adoption of a resolution, to serve as a Member of the Supervisory Board. …
18-10-2023 16:04:59 | Current | EBI | 23/2023 The Management Board of Mycodern SA, with its registered seat in Gdańsk, Poland (the “Company”) informs that today Mr. Łukasz Gostomski has resigned from his position as Member of the Supervisory Board. The resignation did not indicate the reasons for it. Legal basis: §3(1)(7) of Appendix No. …
12-10-2023 15:37:59 | Current | ESPI | 18/2023 Legal basis Article 17 (1) MAR – confidential information. Contents of the report: The Management Board of Mycodern S.A. with its seat in Gdańsk _”Company”_ informs that today it has entered into an agreement with an entity with its seat in Poland _”Partner”_ on the basis of …
Company presentation
Download our company presentation in PDF form to your device
Mycodern is a brand belonging to Mycodern S.A. VAT number: PL6342351875, based at: Jaskowa Dolina 132/20, 80-286 Gdansk and the production plant at ul. Chwaszczyńska 151E 81-571 Gdynia, Poland. 
2023. Mycodern S.A.
